Opus Genetics, Inc. Common Stock
€3.515
EUR
Last updated on --.
24h volume1.00M
24h highest4.0666 EUR
24h lowest3.4859 EUR
24h Price movement-12.70%
IRD recent prices
24 Hours
-12.70%-€0.51212
30 days
-24.44%-€1.138
60 days
-17.68%-€0.75516
90 days
-15.09%-€0.62496
Key data
Previous close4.0275 EUR
Market cap308.04M EUR
Volume1.00M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.1371 EUR
Net income (FY)-92.82M EUR
Revenue (FY)10.40M EUR
Last report dateMay 12, 2026
About Opus Genetics, Inc. Common Stock
HeadquartersDURHAM
Employees (FY)28.00
Revenue per employee (FY)371.47K EUR
Net income per employee (FY)-3.31M EUR
Listed onNasdaq
IRD conversion tables
 |  |
|---|---|
| 0.5 IRD | 1.757 EUR |
| 1 IRD | 3.515 EUR |
| 5 IRD | 17.57 EUR |
| 10 IRD | 35.15 EUR |
| |
|---|---|
| 0.5 EUR | 0.14223 IRD |
| 1 EUR | 0.28446 IRD |
| 5 EUR | 1.422 IRD |
| 10 EUR | 2.844 IRD |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
IRD is trading at €3.515, -12.70% over the last 24 hours. Track live moves on the price chart at the top of this page.
The IRD stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. IRD is currently trading at €3.515, -12.70% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on IRD price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. IRD's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from IRD; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against IRD's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Opus Genetics, Inc. Common Stock's market cap is currently 308.04M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.00M
24h highest4.0666 EUR
24h lowest3.4859 EUR
24h Price movement-12.70%
Start trade with IRD Perpetual
Sign up to trade